Save the Date
Psychedelics in the Treatment of Substance Use Disorders: What Clinicians Need to Know
Date: Wednesday, May 17, 2023
Time: 12:00 – 1:30 pm EDT
Fee: AAAP Members and Annual Meeting 2022 registrants, $25; non-members $50
Disclosure to Learners Statement Continuing Education Credits
Moderator: Karen Drexler, MD, Medical Director, AAAP
Presenters: Michael Bogenschutz, MD, Professor, Department of Psychiatry at NYU Grossman School of Medicine, Director, Langone Center for Psychedelic Medicine New York University; Suresh Muthukumaraswamy, PhD, Associate Professor School of Pharmacy Faculty of Medical and Health Sciences, The University of Auckland; Paul Appelbaum, MD, Psychiatry, Forensic Psychiatry, Elizabeth K. Dollard, Professor of Psychiatry, Medicine and Law, and Director, Division of Law, Ethics and Psychiatry at Columbia University
Invited Panelists: Nora Volkow, MD, Director of the National Institute on Drug Abuse (NIDA); Bertha Madras, PhD, Professor of Psychobiology, Harvard Medical School, McLean Hospital
Special thanks to the AAAP Scientific Program Committee (SPC) and Dr. Nitigna Desai, SPC Chair, for their leadership in organizing this event.
More information coming soon.
Addiction Psychiatry Advanced Psychotherapy Curriculum
Join us for our new monthly live learning series targeted towards Addiction Psychiatry fellows and faculty, developed by the American Academy of Addiction Psychiatry (AAAP) in collaboration with Oregon Health and Science University (OHSU) and NYU School of Medicine.
On-Demand: Addiction Psychiatry Advanced Psychotherapy Curriculum
These on-demand sessions, developed by the American Academy of Addiction Psychiatry (AAAP) in collaboration with Oregon Health and Science University (OHSU) and NYU School of Medicine, are a great way to keep up to date with best practices in patient management on your own schedule.
Clearing the Smoke: Cannabis and Mental Health
A two-part webinar series presented by APA and AAAP
With cannabis becoming more readily available in multiple states, psychiatrists and other mental health professionals need to have the most updated information available on cannabis and to help patients make informed decisions. This activity will provide an overview and updates on cannabis use in patients, mental health impacts and clinical practice recommendations based on the latest research.
Understanding the Final Rule for 42 CFR Part 2 and Next Steps
The American Academy of Addiction Psychiatry, American Psychiatric Association, and American Society of Addiction Medicine hosted a webinar entitled Understanding the Final Rule for 42 CFR Part 2 and Next Steps on August 12, 2020. The webinar slides and recording are now available for viewing.
Watch webinar recording View webinar slides
(recording password: $7FA3*e6)